Similar articles for PMID: 31586004

Year	Number of Results
2007	1
2011	1
2012	3
2013	2
2014	4
2015	8
2016	16
2017	23
2018	25
2019	27
2020	29
2021	29
2022	25
2023	11
2024	0

1

Assessing Radiographic Response to ²²³Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients.

Anand A, Trägårdh E, Edenbrandt L, Beckman L, Svensson JH, Thellenberg C, Widmark A, Kindblom J, Ullén A, Bjartell A. Anand A, et al. J Nucl Med. 2020 May;61(5):671-675. doi: 10.2967/jnumed.119.231100. Epub 2019 Oct 4. J Nucl Med. 2020. PMID: 31586004 Free PMC article.

2

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel.

Uemura K, Miyoshi Y, Kawahara T, Ryosuke J, Yamashita D, Yoneyama S, Yokomizo Y, Kobayashi K, Kishida T, Yao M, Uemura H. Uemura K, et al. BMC Cancer. 2018 May 2;18(1):501. doi: 10.1186/s12885-018-4401-y. BMC Cancer. 2018. PMID: 29716525 Free PMC article.

3

Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer.

McNamara MA, Oyekunle T, Chin BB, Oldan J, Anand A, Ritz M, Shantzer L, Anand M, Armstrong AJ, George DJ. McNamara MA, et al. Prostate. 2019 Jul;79(10):1106-1116. doi: 10.1002/pros.23822. Epub 2019 May 2. Prostate. 2019. PMID: 31045266

4

Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial.

Kitajima K, Igeta M, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Miyake H, Yamamoto S, Narita M, Daimon T, Yamakado K. Kitajima K, et al. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1487-1498. doi: 10.1007/s00259-022-06082-3. Epub 2022 Dec 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36539508

5

²²³Ra Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematologic Toxicity.

Fosbøl MØ, Petersen PM, Kjaer A, Mortensen J. Fosbøl MØ, et al. J Nucl Med. 2018 Apr;59(4):596-602. doi: 10.2967/jnumed.117.195677. Epub 2017 Sep 1. J Nucl Med. 2018. PMID: 28864632 Free article.

6

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Armstrong AJ, Anand A, Edenbrandt L, Bondesson E, Bjartell A, Widmark A, Sternberg CN, Pili R, Tuvesson H, Nordle Ö, Carducci MA, Morris MJ. Armstrong AJ, et al. JAMA Oncol. 2018 Jul 1;4(7):944-951. doi: 10.1001/jamaoncol.2018.1093. JAMA Oncol. 2018. PMID: 29799999 Free PMC article. Clinical Trial.

7

Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer.

Anand A, Heller G, Fox J, Danila DC, Bjartell A, Edenbrandt L, Larson SM, Scher HI, Morris MJ. Anand A, et al. Clin Genitourin Cancer. 2022 Jun;20(3):270-277. doi: 10.1016/j.clgc.2022.02.002. Epub 2022 Feb 9. Clin Genitourin Cancer. 2022. PMID: 35279418 Free PMC article.

8

Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium-223.

Miyoshi Y, Tsutsumi S, Kawahara T, Yasui M, Uemura K, Yoneyama S, Yokomizo Y, Hayashi N, Yao M, Uemura H. Miyoshi Y, et al. BJUI Compass. 2020 Sep 5;2(1):24-30. doi: 10.1002/bco2.43. eCollection 2021 Jan. BJUI Compass. 2020. PMID: 35474664 Free PMC article.

9

Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.

Anand A, Morris MJ, Larson SM, Minarik D, Josefsson A, Helgstrand JT, Oturai PS, Edenbrandt L, Røder MA, Bjartell A. Anand A, et al. EJNMMI Res. 2016 Dec;6(1):23. doi: 10.1186/s13550-016-0173-z. Epub 2016 Mar 9. EJNMMI Res. 2016. PMID: 26960325 Free PMC article.

10

The Prognostic Value of Quantitative Bone SPECT/CT Before ²²³Ra Treatment in Metastatic Castration-Resistant Prostate Cancer.

Dittmann H, Kaltenbach S, Weissinger M, Fiz F, Martus P, Pritzkow M, Kupferschlaeger J, la Fougère C. Dittmann H, et al. J Nucl Med. 2021 Jan;62(1):48-54. doi: 10.2967/jnumed.119.240408. Epub 2020 May 22. J Nucl Med. 2021. PMID: 32444369 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

163 results

Results by year